Additionally, the activation of RSK4 in ESCC cells can elevate CCL22 expression, enhancing the release of soluble ICAM-1 and indirectly influencing STAT3 phosphorylation. This evidence concerns the gene CCL22 and esophageal squamous cell carcinoma.